Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 2
1992 2
1993 1
1994 1
1995 2
1996 2
1997 3
1998 5
1999 6
2000 4
2001 1
2004 1
2005 3
2006 1
2008 1
2009 1
2010 2
2011 5
2012 8
2013 7
2014 6
2015 5
2016 2
2017 2
2018 1
2019 3
2020 2
2021 1
2022 1
2023 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

74 results

Results by year

Filters applied: . Clear all
Page 1
Drug-induced vascular injury--a quest for biomarkers.
Kerns W, Schwartz L, Blanchard K, Burchiel S, Essayan D, Fung E, Johnson R, Lawton M, Louden C, MacGregor J, Miller F, Nagarkatti P, Robertson D, Snyder P, Thomas H, Wagner B, Ward A, Zhang J; Expert Working Group on Drug-Induced Vascular Injury. Kerns W, et al. Among authors: louden c. Toxicol Appl Pharmacol. 2005 Feb 15;203(1):62-87. doi: 10.1016/j.taap.2004.08.001. Toxicol Appl Pharmacol. 2005. PMID: 15694465 Review. No abstract available.
Biomarkers of drug-induced vascular injury.
Brott D, Gould S, Jones H, Schofield J, Prior H, Valentin JP, Bjurstrom S, Kenne K, Schuppe-Koistinen I, Katein A, Foster-Brown L, Betton G, Richardson R, Evans G, Louden C. Brott D, et al. Among authors: louden c. Toxicol Appl Pharmacol. 2005 Sep 1;207(2 Suppl):441-5. doi: 10.1016/j.taap.2005.04.028. Toxicol Appl Pharmacol. 2005. PMID: 15982681 Review.
Severe adverse reactions after cyanoacrylate endovenous ablation.
Louden CD, Clark J, Yanquez F, Labropoulos N, DiMaggio P, Leon LR Jr. Louden CD, et al. J Vasc Surg Cases Innov Tech. 2023 Sep 1;9(4):101309. doi: 10.1016/j.jvscit.2023.101309. eCollection 2023 Dec. J Vasc Surg Cases Innov Tech. 2023. PMID: 37767344 Free PMC article.
Scientific and Regulatory Policy Committee Points-to-consider Paper*: Drug-induced Vascular Injury Associated with Nonsmall Molecule Therapeutics in Preclinical Development: Part I. Biotherapeutics.
Frazier KS, Engelhardt JA, Fant P, Guionaud S, Henry SP, Leach MW, Louden C, Scicchitano MS, Weaver JL, Zabka TS; Society of Toxicologic Pathology Vascular Injury Working Group. Frazier KS, et al. Among authors: louden c. Toxicol Pathol. 2015 Oct;43(7):915-34. doi: 10.1177/0192623315570340. Epub 2015 Feb 26. Toxicol Pathol. 2015. PMID: 25722122 Review.
Delayed expression of osteopontin after focal stroke in the rat.
Wang X, Louden C, Yue TL, Ellison JA, Barone FC, Solleveld HA, Feuerstein GZ. Wang X, et al. Among authors: louden c. J Neurosci. 1998 Mar 15;18(6):2075-83. doi: 10.1523/JNEUROSCI.18-06-02075.1998. J Neurosci. 1998. PMID: 9482794 Free PMC article. Review.
Scientific and Regulatory Policy Committee Points-to-consider Paper*: Drug-induced Vascular Injury Associated with Nonsmall Molecule Therapeutics in Preclinical Development: Part 2. Antisense Oligonucleotides.
Engelhardt JA, Fant P, Guionaud S, Henry SP, Leach MW, Louden C, Scicchitano MS, Weaver JL, Zabka TS, Frazier KS; Society of Toxicologic Pathology Vascular Injury Working Group. Engelhardt JA, et al. Among authors: louden c. Toxicol Pathol. 2015 Oct;43(7):935-44. doi: 10.1177/0192623315570341. Epub 2015 Feb 24. Toxicol Pathol. 2015. PMID: 25717082 Review.
74 results